Hexosamines, insulin resistance, and the complications of diabetes: current status.
about
Mutations in gfpt1 and skiv2l2 cause distinct stage-specific defects in larval melanocyte regeneration in zebrafishGlucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismRegulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytesO-GlcNAcylation: a bridge between glucose and cell differentiationRegulated Hyaluronan Synthesis by Vascular CellsThe role of glucosamine-induced ER stress in diabetic atherogenesisFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyElevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin ResistanceStructural analysis of human glutamine:fructose-6-phosphate amidotransferase, a key regulator in type 2 diabetesInhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 AdipocytesRegulation of hyaluronan synthesis in vascular diseases and diabetesPathogenesis of diabetic cerebral vascular disease complicationAging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway ratsMechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteinsNon-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transitionDiabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.Sporothrix schenckii complex and sporotrichosis, an emerging health problem.A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.O-GlcNAc regulates FoxO activation in response to glucose.Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.Molecular mechanisms of diabetic vascular complicationsGlucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2Hexosamine pathway but not interstitial changes mediates glucotoxicity in pancreatic β-cells as assessed by cytosolic Ca2+ response to glucose.The hexosamine signaling pathway: O-GlcNAc cycling in feast or famineO-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.O-GlcNAcylation: The Sweet Side of the Cancer.Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2O-GlcNAc-ylation in the Nuclear Pore Complex.MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet.The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects.Isoform-specific regulation of the inositol 1,4,5-trisphosphate receptor by O-linked glycosylationO-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans
P2860
Q21145228-63B1328F-2ED4-4669-9489-1C9C7FB62F6DQ21284705-3239C390-95AB-4862-B148-B25ABFD309FDQ24648559-CC79DC6A-94BB-4DFF-B6B6-8D27BF8D4B8AQ26765379-D9C51FD0-E4E7-4840-B26F-EAD41F9C3575Q26786080-D64B1BD6-2565-4999-AE94-A2F4AE02936BQ26830592-2DC09518-7E6C-4CEA-A661-7D7BC1E041F1Q27009399-3B3AD3B7-02C1-4AED-B55E-581838243557Q27652457-25E506FD-FD04-4F87-B7CC-5D1ACE870AD0Q27653066-C61D5E90-5C0F-4948-9E1B-A8821EBA4A3FQ27664569-1A7C4D00-C328-481A-962E-81739F61A9B0Q28083625-8A505ECC-DB6E-42C0-93B1-83CCC08C2E77Q28087462-3AC3882D-0502-48A2-8784-850800FBA49DQ28568308-97AA55F5-B9B3-4647-BB61-78AF4D7B52A3Q28573980-520A21FA-CA90-4B95-B123-96D2AC3A40D8Q28579197-A2FCAF5B-C604-4640-8EFE-ED0AA3F6E2B8Q30239828-6163F1BC-270F-407A-B9CF-9FEDD38A3763Q30397517-69C96869-BA74-472A-86B0-7FA4091E149DQ30437005-07C92784-1595-451F-AB4A-922D157C9A9AQ30439420-03BF6D47-525D-423A-9FE9-BA84F2A34BCFQ30498243-5846D65A-32AC-44AC-B51C-81CDF14C8E14Q33558421-9F540285-AF81-41A1-94AD-BD7AA06B4D2EQ33568231-EF8AFCB8-AD6B-48C9-B509-97897AE24A0EQ33577717-91009C4A-5C5F-4202-99CC-5215B2E3E8D5Q33625053-7A594F5F-7329-4C4C-A6A0-9D5FA8B2D00DQ33628891-4640475B-2E93-43AA-A265-E87A6C0D9C86Q33683197-D3E0B8C2-63D4-48B1-83C7-5FB84EE41490Q33701447-1BB333D0-AE10-4AA3-82D8-B3BF7123C2E1Q33727553-1D026AF5-F8F6-433F-A2E0-C4EAF20EFDE2Q33810805-7DCF6785-EC22-4182-A7CD-B683F94B3B58Q33866466-0BE5BC9F-5A99-470A-AB85-0EE9332473EAQ33873374-A923DBD2-260F-4526-AECA-97135B639BDCQ34101859-6D9BA9DD-3904-49DF-A278-805FE5D1AFC8Q34283956-E8CB60BD-B978-41FF-8587-9AE2D34D55AAQ34355572-BB853B9B-B133-4C17-820C-C140F12CB3B3Q34498193-A47B74A7-697E-4671-A07A-CB6D69B3F61CQ34598611-9DAD286B-6963-41D9-B012-1F72A9E8C3E9Q34761132-8109B86A-66DB-4B6C-BB9A-ED5C595BDBC9Q34919524-EA5DD294-F75A-4A9E-861B-33DA481EA9F9Q34962961-C4D44E97-B851-4507-8369-B37E2F5C140FQ35065486-9BBAEDB6-EE85-42FB-9FC9-69ABB0D0B31E
P2860
Hexosamines, insulin resistance, and the complications of diabetes: current status.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hexosamines, insulin resistance, and the complications of diabetes: current status
@nl
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@ast
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@en
type
label
Hexosamines, insulin resistance, and the complications of diabetes: current status
@nl
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@ast
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@en
prefLabel
Hexosamines, insulin resistance, and the complications of diabetes: current status
@nl
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@ast
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@en
P2860
P3181
P1476
Hexosamines, insulin resistance, and the complications of diabetes: current status.
@en
P2093
Maria G Buse
P2860
P3181
P356
10.1152/AJPENDO.00329.2005
P407
P577
2006-01-01T00:00:00Z